Met-RANTES Treatment for Periodontitis
Author Information
Author(s): Repeke Carlos Eduardo, Ferreira Samuel Barros Jr., Vieira Andreia Espindola, Silveira Elcia Maria, Avila-Campos Mario Julio, da Silva João Santana, Santos Carlos Ferreira, Campanelli Ana Paula, Trombone Ana Paula Favaro, Garlet Gustavo Pompermaier
Primary Institution: Department of Biological Sciences, School of Dentistry of Bauru, São Paulo University - FOB/USP, Bauru, Sao Paulo, Brazil
Hypothesis
Does met-RANTES treatment modulate the outcome of experimental periodontitis in mice?
Conclusion
Met-RANTES treatment shows a dose-dependent effect on reducing inflammation and bone loss in experimental periodontitis, but high doses may impair host defense.
Supporting Evidence
- Met-RANTES treatment significantly reduced alveolar bone loss and inflammatory cell influx.
- High doses of met-RANTES increased bacterial load and CRP response.
- Lower doses effectively reduced pro-inflammatory cytokines without impairing host defense.
Takeaway
This study tested a medicine called met-RANTES to see if it helps mice with gum disease. It found that the right amount helps reduce damage, but too much can make it harder for the mice to fight infections.
Methodology
C57Bl/6 mice were infected with Aggregatibacter actinomycetemcomitans and treated with varying doses of met-RANTES, followed by evaluation of bone loss and inflammatory response.
Potential Biases
Potential bias in the interpretation of results due to the specific animal model used.
Limitations
The study was conducted in mice, which may not fully represent human responses.
Participant Demographics
8-week-old male C57BL/6 wildtype mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website